ASTRO Annual Meeting

Healio.com brings you the highlights from the American Society for Radiation Oncology Annual Meeting. Refer back to this page often to read the latest news from ASTRO, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News Coverage

First-line dasatinib plus pegylated-interferon alpha 2b induces deep molecular responses in CML

December 7, 2015
ORLANDO, Fla. — The first-line combination of dasatinib with pegylated-interferon alpha 2b conferred a high rate of deep molecular response…
Meeting News CoveragePerspective

Hydroxyurea shows promise for stroke prevention in pediatric patients with sickle cell anemia

December 7, 2015
ORLANDO, Fla. — The maximum tolerated dose of hydroxyurea appeared noninferior to chronic transfusions for maintaining transcranial Doppler…
Meeting News CoveragePerspective

Venetoclax produces durable responses in high-risk CLL

December 7, 2015
ORLANDO, Fla. — Venetoclax monotherapy conferred sustained remissions and produced a high overall response rate in patients with relapsed…
Meeting News Coverage

Gene therapy may reduce, eliminate disease symptoms for patients with hemoglobinopathies

December 7, 2015
ORLANDO, Fla. — Gene therapy using autologous hematopoietic stem cells transduced with an experimental lentiviral vector improved the long-term…
Meeting News CoveragePerspective

Luspatercept increases hemoglobin levels, reduces transfusion burden in myelodysplastic syndromes

December 7, 2015
ORLANDO, Fla. — The fusion protein luspatercept led to a sustained increase in hemoglobin levels and reduced the transfusion requirement among…
Meeting News Coverage

Novel flu vaccine strategy improves protection for oncology patients

December 7, 2015
A booster of high-dose influenza vaccine administered to patients with plasma cell disorders reduced influenza infections by approximately 14%…
Meeting News CoveragePerspective

Rituximab extends EFS in B-cell precursor ALL

December 7, 2015
ORLANDO, Fla. — The addition of rituximab to the pediatric-inspired GRAALL protocol prolonged EFS among adult patients with CD20-positive…
Meeting News CoveragePerspective

Single-agent ibrutinib significantly prolongs survival in older patients with CLL

December 7, 2015
ORLANDO, Fla. — Ibrutinib monotherapy yielded superior PFS, OS, EFS and overall response rates compared with chlorambucil in older patients…
Meeting News CoveragePerspective

Ixazomib prolongs PFS in relapsed, refractory multiple myeloma

December 6, 2015
ORLANDO, Fla. — The addition of the oral proteasome inhibitor ixazomib to lenalidomide and dexamethasone significantly prolonged PFS without…
Meeting News CoveragePerspective

Daratumumab combination confers durable responses in relapsed, refractory multiple myeloma

December 6, 2015
ORLANDO, Fla. — The combination of daratumumab, lenalidomide and dexamethasone demonstrated a favorable benefit–risk profile and yielded…